Global Medical REIT faces significant structural headwinds as evidenced by a collapse in FFO per share from $6.58 in 2025Q1 to $0.28 in 2025Q4. The company's reliance on external financing to cover capital expenditures, which surged to $105.1M in 2025Q4, creat...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2025Latest Nov 4, 2025 | $1.12+6.7% vs $1.05 | $41M+8.3% vs $37M |
Q3 2025 Aug 5, 2025 | $1.15+0.0% vs $1.15 | $41M+14.7% vs $36M |
Q2 2025 May 7, 2025 | $0.22+0.0% vs $0.22 | $35M-2.4% vs $35M |
Q1 2025 Feb 27, 2025 | $0.22+2100.0% vs $0.01 | $35M+0.2% vs $35M |
Chiron Real Estate reported second-quarter results as it continues to reposition its portfolio toward senior housing and away from outpatient medical real estate, with management emphasizing capital recycling, leadership additions and a growing investment pipeline. Chief Executive Officer Mark Decker Jr. said the company's existing portfolio remained operationally stable while it pursued a broader strategic
Chiron Real Estate reported second-quarter results as it continues to reposition its portfolio toward senior housing and away from outpatient medical real estate, with management emphasizing capital recycling, leadership additions and a growing investment pipeline.
Benchmark GMRE against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Global Medical REIT Inc. (GMRE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $35.74 | $94.26M | 115.29 | 7.08% | -8.18% | -2.23% | 63.51% | |
| $14.27 | $407.72M | 184.37 | 4.67% | 16.85% | 4.96% | — | |
| $20.74 | $527.05M | -16.46 | -3.24% | -13.12% | -11.56% | — | |
| $21.98 | $979.23M | 7.11 | -0.75% | 48.46% | 15.86% | — | |
| $17.96 | $6.3B | -25.30 | -6.92% | -7.59% | -1.91% | — | |
| $20.48 | $14.12B | 204.80 | 4.52% | 8.6% | 2.89% | — |
Global Medical REIT Inc. (GMRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when GMRE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Global Medical REIT Inc. (GMRE) stock FAQ — growth, dividends, profitability & financials explained
Global Medical REIT Inc. (GMRE) reported $148.2M in revenue for fiscal year 2025.
Global Medical REIT Inc. (GMRE) grew revenue by 7.1% over the past year. This is steady growth.
Global Medical REIT Inc. (GMRE) reported a net loss of $12.1M for fiscal year 2025.
Yes, Global Medical REIT Inc. (GMRE) pays a dividend with a yield of 63.51%. This makes it attractive for income-focused investors.
Global Medical REIT Inc. (GMRE) has a return on equity (ROE) of -2.2%. Negative ROE indicates the company is unprofitable.
Global Medical REIT Inc. (GMRE) generated Funds From Operations (FFO) of $47.7M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Global Medical REIT Inc. (GMRE) offers a 63.51% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
